Guest Open Access Plus | Free Content | About | Sign in | New Users: Sign up | Mark List  

Current Respiratory Medicine Reviews

Volume 7 Issue 5
ISSN: 1573-398X
eISSN: 1875-6387


   All Titles

  Mesothelioma - Epidemiology and Management
  pp.364-376 (13) Authors: Patricia Tai, Edward Yu, Avi Assouline, Kurian Joseph

Mesothelioma is an uncommon tumor. It has a latency period of 20-40 years. The most important risk factor is asbestos exposure. Prognosis of mesothelioma is generally poor with high case-fatality rate, and research to improve the outcome of this disease is on-going worldwide. Due to its rarity, management by a multidisciplinary team with experience is recommended. Carefully selected patients may benefit from tri-modality (surgery, radiotherapy and chemotherapy) treatment. The management of pleural and peritoneal mesothelioma is summarized in this review. Recent advances in chemotherapy and biologic response modifiers are promising.

  Keywords: Asbestos, epidemiology, treatment, Mesothelioma, tri-modality (surgery, radiotherapy and chemotherapy), pleural and peritoneal mesothelioma, malignant meosothelioma
  Affiliation: Department of Radiation Oncology, Allan Blair Cancer Center, 4101 Dewdney Avenue, Regina, Saskatchewan, S4T 7T1, Canada.
  Key: New Content Free Content Open Access Plus Subscribed Content

Bentham Science Publishers


  Copyright © 1994 - 2015   Bentham Science Publishers